Moderna stock Forecast 2022, 2023, 2025, 2030, 2040 and 2050

Moderna stock Forecast 2022, 2023, 2025, 2030, 2040 and 2050

 

 

About Moderna stock forecast :

Moderna Stock is considered a buy, as financial stocks are currently dropping by as much as 60%.
Investors and traders can take advantage of this price reduction opportunity to buy and retain assets. This is because the asset is still promising and is considered a profitable asset in the long run.
In addition, it is best to do an analysis and research before deciding to invest in this stock. Also, invest what you can afford to lose.

 

Moderna stock Forecast 2022, 2023, 2025, 2030, 2040 and 2050
Moderna stock Forecast 2022, 2023, 2025, 2030, 2040 and 2050

 

Moderna stock Forecast 2022

After Moderna reported earnings for the first quarter of 2022 on May 4, 2022, investors are having a hard time deciding what to expect.

MRNA has provided a $ 21 billion estimate of the value of APA that could be realized as revenue or revenue in 2022, but the company said that this year’s company’s actual product sales make sense. I will guide you with.

A major variable factor is the increase in new orders for COVID-19 boosters in various markets, especially in the United States. At the company’s first-quarter 2022 earnings briefing, Moderna is likely to be confident that new orders for COVID-19 boosters from the United States are “nationally aware of the need for boosters.” I emphasized. In addition, the majority of future US orders could be positive for Moderna as better vaccine prices are expected in the market in the future. COVID vaccine prices should rise as the private sector is expected to play a more active role in vaccine procurement and vaccine pricing.

 

Moderna stock forecast for the year 2022 – Target I – $139 & Target II – $175.

 

Moderna stock Forecast 2023

Analysts and experts predict that Moderna shares will reach a potential low of $ 214 in 2023. Moderna shares are expected to reach high price levels from the average price level of $ 214 to $ 234.

 

Also read – IDEX stock Forecast 2022, 2023, 2025, 2030, 2040 and 2050

 

Moderna stock Forecast 2024

Moderna’s share price is expected to reach the floor level of $ 136.2. Moderna shares can reach the highest price level of $ 162.6 throughout the year, with an average price level of $ 146.7.

 

Also read – Binance Price Prediction 2022, 2023, 2024, 2025, 2030, 2035, 2040 and 2050

 

Moderna stock Forecast 2025

Studies show that the price of Moderna shares is expected to reach a minimum of $ 288. Moderna’s share price averages $ 304 and can reach the highest price level of $ 324.

 

Moderna stock Forecast 2030

Experts and professional analysts predict that Moderna’s share price will reach the lowest price level of $ 153.08. The acquisition cost of this financial asset is expected to reach a maximum price level of $ 345 and an average price level of $ 375.

Moderna shares offer promising investment opportunities for traders and investors. The stock is known for its year-over-year performance and has the opportunity to benefit interested investors.

 

Moderna stock Forecast 2040

If it is difficult to predict the future sales of a company, it is just as difficult to value the stock. This view is reflected in sell-side analysts’ price targets for mRNA. Moderna’s minimum price target is $ 80, down -41% from current price levels. The average target price for MRNA is $ 225.29, which means that its share could rise by as much as + 66%. Wall Street analysts, who are the most bullish on MRNA, believe that the company’s stock has the potential for a + 273% capital increase.

Moderna stock forecast for the year 2040 – Target I – $3740 & Target II – $3895.

 

Moderna stock Forecast 2050

According to the S & P Capital IQ -Forecasts consensus stopline, Moderna’s revenue is expected to increase by + 19% in 2022, followed by a -55% and -29% decline in 2023 and 2024, respectively. .. Sell-side analysts predict that mRNA will then return to positive revenue growth areas in 2025 and 2026 with + 24% and + 18% revenue growth, respectively.

However, there are upward options that may improve the long-term growth prospects of mRNA. As of March 31, 2022, Moderna’s cash and investments were $ 19.3 billion. That’s about 36% of the company’s $ 54 billion market capitalization, based on its final transaction price of $ 135.80 on May 10, 2022. If MRNA can allocate this excess, the company’s long-term finances are market expectations if it has sufficient capital to invest in value-added R & D (R & D) and M & A (merger and acquisition) projects. May be better than.

 

Moderna stock forecast for the year 2040 – Target I – $15742 & Target II – $17420.

 

Moderna stock Forecast 2022, 2023, 2025, 2030, 2040 and 2050

 

YearForecast IForecast II
2022$139$175
2023$214$234
2024$288$324
2025$345$375
2030$824$910
2040$3740$3895
2050$15742$17420

Leave a Comment